Abstract
More than 100,000 permanent pacemakers are implanted in patients in the United States each year. From the most basic fixed-rate ventricular pacemakers that first became commercially available over 40 years ago, pacing systems have evolved dramatically in design and sophistication; current systems are both remarkably durable and reliable. This improvement in performance has been accompanied by an almost equally dramatic increase in complexity, so that patients with permanent pacemakers typically require follow-up in clinics staffed by specially trained individuals. In this chapter, we discuss in some detail the current and emerging indications for temporary and permanent pacing. In addition, we review some of the basic concepts and recent advances in pacing techniques and technology that are applicable to the various subsets of patients
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Gregoratos G, for the Task Force on Practice Guidelines (Committee on Pacemaker Implantation) of the American College of Cardiology/American Heart Association. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1998;31:1175– 209.
Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am J Cardiol 1992; 69: 331–338.
Buckingham TA, Volgman AS, Wimer E. Trends in pacemaker use: results of a multicenter registry. Pacing Clin Electrophysiol 1991; 14: 1437–1439.
Ferrer MI. The sick sinus syndrome. Circulation 1973; 47: 635–641.
Linde C. How to evaluate quality-of-life in pacemaker patients: problems and pitfalls. Pacing Clin Electrophysiol 1996; 19: 391–397.
Adornato E, Bacca F, Polimeni RM. Ventricular single-chamber RR pacing in comparison to dual-chamber RR pacing: preliminary results of an Italian multicenter trial (Abstract). Pacing Clin Electrophysiol 1993; 16: 1147.
Barrington WW, Windle JR, Easley AA, Rundlett R, Eisenger G. Clinical comparison of acute single to dual chamber pacing in chronotropically incompetent patients with left ventricular dysfunction. Pacing Clin Electrophysiol 1995; 18: 1109–1113.
Connolly SJ, Kerr C, Gent M, Yusuf S. Dual-chamber versus ventricular pacing: critical appraisal of current data. Circulation 1996; 94: 578–583.
Brandt J, Schuller H. Pacing for sinus node disease: a therapeutic rationale. Clin Cardiol 1994;17:495– 498.
Lamas GA, Estes NM, Schneller S, Flaker GC. Does dual chamber pacing prevent atrial fibrillation? The need for a randomized controlled trial. Pacing Clin Electrophysiol 1992; 15: 1109–1113.
Jahangir A, Shen W-K, Neubauer SA, Ballard DJ, Hammill SC, Hodge DO, et al. Relation between mode of pacing and long-term survival in the very elderly. J Am Coll Cardiol 1999; 33: 1208–1216.
Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88: 1045–1053.
Sgarbossa EB, Pinski SL, Maloney JD. The role of pacing modality in determining long-term survival in the sick sinus syndrome. Ann Intern Med 1993; 119: 359–365.
Sgarbossa EB, Pinski SL, Trohman RG, Castle LW, Maloney JD. Single-chamber ventricular pacing is not associated with worsening heart failure in sick sinus syndrome. Am J Cardiol 1994; 73: 693–697.
Lamas GA, Orav J, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SKS, et al., for the Pacemaker Selection in the Elderly Investigations. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338: 1097–1104.
Anderson HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, et al. Long-term follow-up of patients with a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997; 350: 1210–1216.
Wharton JM, Sorentino RA, Campbell P, Gonzalex-Zuelgaray J, Keating E, Curtis A, et al. PACA-TACH Investigators. Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardia-bradycardia syndrome. Preliminary results of the pacemaker atrial tachycardia trial (Abstract). Circulation 1998; 98: I–494.
Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000; 342 (19): 1385–1391.
a. Lamas GA. Presentation at North American Society of Pacing and Electrophysiology, 2001.
Anderson HR, Nielsen JC. Pacing in the sick sinus syndrome—need for a prospective randomized trial comparing atrial with dual chamber pacing. Pacing Clin Electrophysiol 1998; 21: 1175–1179.
Anderson HR, Nielsen JC, Thompsen PE, Thuesen L, Vesterlund T, Pedersen AK, et al. Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome. Circulation 1998; 98: 1315–1321.
Bohm A, Pinter A, Szekely A, Preda I. Clinical observations with long-term atrial pacing. Pacing Clin Electrophysiol 1998; 21: 246–249.
Charles RG, McComb JM. Systematic trial of pacing to prevent atrial fibrillation (STOP-AF). Heart 1997; 78: 224–225.
Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-base cohort. The Framingham Heart Study. JAMA 1994; 271: 840–844.
Wolfe PA, Abbott RD, Kannel WB. Atrial fibrillation as a risk factor for stroke: the Framingham Heart Study. Stroke 1991; 22: 983–988.
Coumel P, Friocourt P, Mugica J, Attuel P, LeCler JF. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. Pacing Clin Electrophysiol 1983;6:552– 556.
Goel BG, Han J. Atrial ectopic activity associated with sinus bradycardia. Circulation 1970;42:853– 858.
Mehra R. How might pacing prevent atrial fibrillation? In: Murgatroyd FD, Camm AJ, ed. Nonpharmacologic Management of Atrial Fibrillation. Futura Publishing, Armonk, NY, 1997, pp. 283–307.
Wijffels M, Kirchof C, Dorland R, Alessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92: 1954–1958.
Palma EC, Kedarnath V, Vankawalla V, Andrews CA, Hanson S, Furman S, et al. Effect of varying atrial sensitivity, AV interval, and detection algorithm on automatic mode switching. PACE 1996; 19: 1734–1739.
Lam CTF, Lau C-P, Leung S-K, Tse H-F, Ayers G. Improved efficacy of mode switching during atrial fibrillation using automatic atrial sensitivity adjustment. PACE 1999; 22: 17–25.
Kalalvand K, Tan K, Kotsakis A, Bucknall C, Sulke N. Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias. J Am Coll Cardiol 1997; 30: 496–504.
Marshall HJ, Harris ZI, Griffith MJ, Holder RL, Gammage MD. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. Circulation 1999; 99: 1587–1592.
Gillis AM, Wyse G, Connolly SJ, Dubuc M, Philippon F, Yee R, et al., for the Paroxysmal Atrial Fibrillation Investigators. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999; 99: 2553–2558.
Stabile G, Senatore G, De Simone A, Turco P, Coltorti F, Nocerino P, et al. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrence. J Cardiovasc Electrophysiol 1999; 10: 2–9.
Guerra PG, Lesh MD. The role of nonpharmacologic therapies for the treatment of atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10: 450–460.
Saksena S, Prakash A, Hill M, Krol RB, Munsif AN, Mathew PP, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996; 28: 687–694.
Michaelson M, Jonzon A, Riesenfeld T. Isolated congenital complete heart block in adult life: a prospective study. Circulation 1995; 92: 442–449.
Friedman RA. Congenital complete AV block: pace me now or pace me later. Circulation 1995; 92: 283–285.
Rotman M, Triebwasser JH. A clinical and follow-up study of right and left bundle branch block. Circulation 1975; 51: 477–484.
Schneider JF, Thomas HE, Kreger BE, McNamara PM, Kannel WB. Newly acquired left bundle branch block: the Framingham study. Ann Intern Med 1979; 90: 303–310.
Schneider JF, Thomas HE, Kreger DE, McNamara PM, Sorlie P, Kannel WB. Newly acquired right bundle branch block: the Framingham study. Ann Intern Med 1980; 92: 37–44.
Dhingra RC, Palileo E, Strasberg, Swiryn S, Bauernfeind RA, Wyndham CRC, et al. Significance of the HV interval in 517 patients with chronic bifasicular block. Circulation 1981; 64: 1265–1275.
McAnulty JH, Rahimtoola SH, Murphy E, DeMots H, Ritzman L, Kanarek PE, et al. Natural history of “high risk” bundle branch block: final report of a prospective study. N Engl J Med 1982; 307: 137–143.
Scheinman MM, Peters RW, Sauve MJ, Desai J, Abbott JA, Cogan J, et al. The value of the HQ interval in patient with bundle branch block and the role of prophylactic pacing. Am J Cardiol 1982; 50: 1316–1322.
Morady F, Higgins J, Peters RW, Schwartz AB, Shen EN, Bhandari A, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 1984; 54: 587–591.
Dhingra RC, Wyndham C, Bauernfeind, Swiryn C, Amat-y-Leon F, Towne W, et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifasicular block. Circulation 1979; 60: 1455–1464.
Petrac D, Radic B, Birtic K, Gjurovic J. Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope. PACE 1996; 19: 784–792.
Woelfel AK, Simpson RJ, Gettes LS, Foster J. Exercise-induced distal atrioventricular block. J Am Coll Cardiol 1983; 2: 578–584.
Kaul U, Dev V, Narula J, Malhotra AK, Talwar KK, Bhatia ML. Evaluation of patients with bundle branch block and “unexplained” syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress. PACE 1988; 11: 289–297.
Twidale N, Heddle WF, Tonkin AM. Procainamide administration during electrophysiologic study: utility as a provocative test for intermittent atrioventricular block. PACE 1988; 11: 1388–1397.
Englund A, Bergfeldt L, Rosenqvist. Disopyramide stress test: a sensitive and specific tool for predicting impending high degree atrioventricular block in patients with bifasicular block. Br Heart J 1995; 74: 650–655.
Connolly SJ, Sheldon R, Roberts RS, Gent M, on behalf of the Vasovagal Pacemaker Study Investigators. J Am Coll Cardiol 1999; 33: 16–20.
Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A, for the VASIS investigators. Dual chamber pacing in the treatment of neurally mediated tilt positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 2000; 102: 294–299.
Benditt DG. Cardiac pacing for prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 21–23.
Eldar M, Griffin JC, Abbott JA, Benditt D, Bhandari A, Herre JM, et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987; 10: 600–607.
Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high risk patients with long QT syndrome. Circulation 1991; 84: 1524–1529.
Eldar M, Griffin JC, VanHare GF, Witherell C, Bhandarim A, Benditt D, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992; 20: 830–837.
Heinz G, Kratochwill C, Koller-Strametz J, Kreiner G, Grimm M, Grabenwoger M, et al. Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long-term implications. PACE 1998; 21: 422–429.
Scott, Dark JH, McComb JM. Sinus node function after cardiac transplantation. J Am Coll Cardiol 1994; 24: 1334–1341.
DiBiase, a Tse T-M, Schnittger I, Wexler L, Stinson EB, Valentine HA. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991;67:1385– 1389.
Scott CD, Omar I, McComb JM, Dark JH, Bexton RS. Long-term pacing in heart-transplant recipients is usually unnecessary. PACE 1991; 14: 1792–1796.
Payne ME, Murray KD, Watson KM. Permanent pacing in heart transplant recipients: underlying causes and long-term results. J Heart Lung Transplant 1991; 10: 738–742.
Ellenbogen KA, Szentpetery S, Katz MR. Reversibility of prolonged chronotropic dysfunction with theophylline following orthotopic cardiac transplantation. Am Heart J 1988; 202: 202–206.
Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and B-adrenergic blocker therapy. Circulation 1992; 85: 2149–2161.
Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731–2742.
Pak PH, Maughan L, Baughman KL, Kieval RS, Kass DA. Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. Circulation 1998; 98: 242–248.
Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, et al. Dual-chamber
pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435–441.
Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS, for the MPATHY Study investigators. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, crossover study. Circulation 1999; 99: 2927–2933.
Gadler F, Linde C, Ryden L. Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1999; 83: 553–557.
Linde C, Gadler F, Kappenberger L, Ryden L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. Am J Cardiol 1999; 83: 903–907.
Van Orden Wallace CJ. Dual-chamber pacemakers in the management of severe heart failure. Crit Care Nurs Q 1998; 18: 57–67.
Ellenbogen KA, Gilligan DM, Wood MA, Morillo C, Barold SS. The pacemaker syndrome—a matter of definition. Am J Cardiol 1997; 79: 1226–1229.
Hochleitner M, Hortnagl H, Ng C-K, Hortnagl H, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 198–202.
Hochleitner M, Hortnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70: 1320–1325.
Kataoka H. Hemodynamic effect of physiologic dual chamber pacing in a patient with end-stage dilated cardiomyopathy; a case report. PACE 1991; 14: 1330–1335.
Auricchio Sommariva L, Salo RW, Scafuri A, Chiarello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. PACE 1993; 16: 2034–2043.
Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short AV delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995; 26: 967–973.
Innes D, Leitch JW, Fletcher PJ. VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure. PACE 1994; 17: 959–965.
Gilligan DM, Sargent DA, Wood MA, Ellenbogen KA. A double-blind, randomized, crossover trial of dual chamber pacing with an “optimized” versus a nominal atrio-ventricular delay in symptomatic left ventricular dysfunction (Abstract). J Am Coll Cardiol 1998; 31: 389A.
Karpawich PP, Vincent JA. Ventricular pacing does make a difference: improved left ventricular function with septal pacing (Abstract). PACE 1994; 17: 820.
Giudici MC, Thornburg GA, Buck DL, Coyne EP, Walton MC, Paul DL, et al. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol 1997; 79: 209–212.
Cowell R, Morris-Thurgood J, Ilsey C, Paul V. Septal short atrioventricular delay pacing: additional hemodynamic improvements in heart failure. PACE 1994; 17: 1980–1983.
Gold MR, Shorofsky SR, Metcalf MD, Feliciano Z, Fisher ML, Gottlieb SS. The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 79: 679–681.
Brockman RG, Olsovsky MR, Shorofsky SR, Gold MR. The acute hemodynamic effects of pacing site and mode in congestive heart failure (Abstract). J Am Coll Cardiol 1998; 31: 389A.
Foster AH, Gold MR, McLaughlin JS. Acute hemodynamic effects of atrio-biventricular pacing in humans. Ann Thorac Surg 1995; 59: 294–300.
Bakker PF, Meijburg H, de Jonge N, van Mechelen R, Wittkampf F, Mower M, et al. Beneficial effects of biventricular pacing in congestive heart failure (abstract). PACE 1994; 17: 820.
Blanc JJ, Etienne Y, Gilard M, Mansourati J, Munier S, Boschat J, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997; 96: 3273–3277.
Kass DA, Chen C-H, Curry C, Talbot M, Berger R, Fetics B, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99: 1567–1573.
Cazeau S, Ritter P, Lazarus A, Gras D, Bakdach H, Mundler O, et al. Multisite pacing for end-stage heart failure. PACE 1996; 19: 1748–1757.
Daubert C, Ritter P, Cazeau S, Gras, Lazzarus A, Mabo P. Permanent biventricular pacing in dilated cardiomyopathy: is a totally endocardial approach technically feasible (Abstract) PACE 1996; 19: 699.
Maloney JD, Martin R, Chodinella, Milner L, Emanuele T. Transvenous bi-atrial and biventricular pacing is technically feasible for management of arrhythmias and end-stage heart failure (Abstract). PACE 1996; 19: 699.
Jais P, Douard H, Shah DC, Barold S, Barat J-L, Clement J. Endocardial biventricular pacing. PACE 1998; 21: 2128–2131.
Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen A-K, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. PACE 1998; 21: 2249–2255.
Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, et al., for the Pacing Therapies for Congestive Heart Failure Study Group. Circulation 1999; 99: 2993–3001.
Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert J-C. The multisite stimulation in cardiomyopathies (MUSTIC) study investigators. N Engl J Med 2001; 344: 873–880.
Abraham W. MUSTIC Results. Presentation at American College of Cardiology Annual Scientific Session, 2001.
Kunstadt D, Punja M, Cagin, Fernandez P, Levitt B, Yuccoglu YZ. Bifasicular block: a clinical and electrophysiologic study. Am Heart J 1973; 86: 173–181.
Santini M, Carrara P, Benhar M. Possible risks of general anesthesia in patients with intraventricular conduction disturbances. PACE 1980; 3: 130–137.
Mikell FL, Weir EK, Chesler E. Perioperative risk of complete heart block in patients with bifasicular block and prolonged PR interval. Thorax 1981; 36: 14–17.
Gauss A, Hubner C, Radermacher P, Georgieff M, Schutz W. Perioperative risk of bradyarrhythmias in patients with asymptomatic chronic bifasicular block or left bundle branch block. Anesthesiology 1998; 88: 679–687.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peters, R.W., Gold, M.R. (2002). Bradyarrhythmias and Indications for Pacing. In: Ganz, L.I. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-090-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-090-2_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-218-6
Online ISBN: 978-1-59259-090-2
eBook Packages: Springer Book Archive